Supporting this hypothesis is the study by Balatzenko et al. (2011) who investigated the impact of BCR‐ABL fusion types in association with multi‐drug resistance (MDR1) gene on hematological parameters in 89 Indian patients with CML. The gene discussed is ABCB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.